Best Janus Kinase Inhibitor for primary myelofibrosis
3 Janus Kinase Inhibitor drugs indicated for primary myelofibrosis, ranked by our independent rating. The current highest-rated is jakafi. Compare them with all treatments for primary myelofibrosis or the full Janus Kinase Inhibitor class. Not medical advice — always consult a professional.
Top janus kinase inhibitor for primary myelofibrosis: 1. Jakafi · 2. Jakafi XR · 3. Opzelura
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Jakafi | Not yet rated | Prescription | — | View → |
| 2 | Jakafi XR | Not yet rated | Prescription | — | View → |
| 3 | Opzelura | Not yet rated | Prescription | — |
Full ranking · 3 drugs
jakafi
PrescriptionFDA-sourced
Janus Kinase Inhibitor used to treat polycythemia vera, primary myelofibrosis.
janus kinase inhibitorkinase inhibitorpolycythemia vera
Price varies
jakafi xr
Frequently asked
- What is the best janus kinase inhibitor for primary myelofibrosis?
- By our independent rating, jakafi currently ranks highest among Janus Kinase Inhibitor drugs used for primary myelofibrosis. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which janus kinase inhibitor drugs treat primary myelofibrosis?
- pharmaranks lists 3 Janus Kinase Inhibitor products indicated for primary myelofibrosis, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.